Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 7779175)

1.

Access to specialty care.

Kassirer JP.

N Engl J Med. 1994 Oct 27;331(17):1151-3. No abstract available. Erratum in: N Engl J Med 1994 Dec 1;331(22):1535.

PMID:
7779175
2.

Access to specialty care.

Zink TK.

N Engl J Med. 1995 Feb 16;332(7):475; author reply 475-6. No abstract available.

PMID:
7824034
3.

Specialty care works hard to assure its resurgence.

Diamond F.

Manag Care. 2003 Aug;12(8):18-23. No abstract available.

4.
5.

Direct access to specialists not necessarily more expensive.

[No authors listed]

Capitation Rates Data. 2001 Feb;6(2):15-7. No abstract available.

PMID:
11263423
6.

Access to specialty care and medical services in community health centers.

Cook NL, Hicks LS, O'Malley AJ, Keegan T, Guadagnoli E, Landon BE.

Health Aff (Millwood). 2007 Sep-Oct;26(5):1459-68.

7.
8.

Access to specialty care.

Diamond C.

N Engl J Med. 1995 Feb 16;332(7):474; author reply 475-6. No abstract available.

9.
10.

Coronary thrombolysis.

[No authors listed]

Ann Intern Med. 1990 Jul 15;113(2):171. No abstract available.

PMID:
2113785
11.

Quality of primary care practice in a large HMO according to physician specialty.

Grumbach K, Selby JV, Schmittdiel JA, Quesenberry CP Jr.

Health Serv Res. 1999 Jun;34(2):485-502.

12.

Lessons we have learned from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries.

Holmes DR Jr, Califf RM, Topol EJ.

J Am Coll Cardiol. 1995 Jun;25(7 Suppl):10S-17S. Review.

PMID:
7775708
13.

Carve outs and related models of contracting for specialty care: framework and highlights of a workshop.

Friedman B, Devers K, Hellinger F, Fraser I.

Am J Manag Care. 1998 Jun 25;4 Suppl:SP11-21; discussion SP23-6. No abstract available.

14.

Specialty hospitals: their impact and their long-term viability.

Smith RE.

J Okla State Med Assoc. 2004 Nov;97(11):492-6. No abstract available.

PMID:
15609496
15.

Solving the issue of patient arrival time: a call for vigilant action.

Alexandrov AW.

Stroke. 2007 Aug;38(8):2219-20. Epub 2007 Jul 5. No abstract available.

16.

New developments in thrombolytic therapy.

Collen D, Gold HK.

Adv Exp Med Biol. 1990;281:333-54. Review.

PMID:
2129372
17.

Cost, uncertainty, and doctors' decisions. The case of thrombolytic therapy.

Lessler DS, Avins AL.

Arch Intern Med. 1992 Aug;152(8):1665-72.

PMID:
1497400
18.

Public policy. A doctor's perspective.

Hirschhorn K.

Mt Sinai J Med. 1997 Mar;64(2):105-7. No abstract available.

PMID:
9057467
19.
20.

Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, Kristinsson A, Moulopoulos S, Paolasso EA, Van der Werf T, et al.

Arch Intern Med. 1994 Oct 10;154(19):2237-42.

PMID:
7944845
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk